Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

iRhythm Technologies (IRTC) Stock Forecast & Price Target

$96.76
-1.85 (-1.88%)
(As of 01:48 PM ET)

iRhythm Technologies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$131.22
35.62% Upside
High Forecast$165.00
Average Forecast$131.22
Low Forecast$110.00
TypeCurrent Forecast
7/4/23 to 7/3/24
1 Month Ago
6/4/23 to 6/3/24
3 Months Ago
4/5/23 to 4/4/24
1 Year Ago
7/4/22 to 7/4/23
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$131.22$134.00$135.11$151.00
Forecasted Upside35.62% Upside31.53% Upside28.98% Upside25.05% Upside

IRTC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IRTC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

iRhythm Technologies Stock vs. The Competition

TypeiRhythm TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.71
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside35.62% Upside989.75% Upside12.08% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/20/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Polark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$115.00+17.16%
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$133.00 ➝ $122.00+18.82%
5/3/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$137.00 ➝ $138.00+24.46%
2/23/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$142.00 ➝ $133.00+23.30%
12/22/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$115.00 ➝ $133.00+23.91%
12/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$110.00+23.37%
The Only Retirement Stock You'll Ever Need? Discover Now (Ad)

There is a little region of America called Loudoun County. The value of each square mile has shot up close to $10 billion... It's also the source of the single greatest investment opportunity of our generation...

Get all the urgent details here >>>
10/11/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$149.00 ➝ $135.00+55.62%
8/4/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$125.00 ➝ $165.00+41.72%
7/18/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$130.00+28.55%
6/8/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$165.00 ➝ $140.00+37.34%
5/5/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
2/7/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$150.00+41.99%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:14 PM ET.

IRTC Forecast - Frequently Asked Questions

What is iRhythm Technologies's stock forecast and purchase recommendation?

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for iRhythm Technologies is $131.22, with a high forecast of $165.00 and a low forecast of $110.00. The consensus rating for iRhythm Technologies stock is Buy based on the current 8 buy ratings for IRTC. Learn more on IRTC's analyst rating history.

Do Wall Street analysts like iRhythm Technologies more than its competitors?

Analysts like iRhythm Technologies more than other "medical" companies. The consensus rating for iRhythm Technologies is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how IRTC compares to other companies.

Is iRhythm Technologies being upgraded by Wall Street analysts?

Over the previous 90 days, iRhythm Technologies's stock had 1 upgrade by analysts.

Does iRhythm Technologies's stock price have much upside?

According to analysts, iRhythm Technologies's stock has a predicted upside of 29.37% based on their 12-month stock forecasts.

What analysts cover iRhythm Technologies?

iRhythm Technologies has been rated by research analysts at Canaccord Genuity Group, Needham & Company LLC, and Wolfe Research in the past 90 days.


This page (NASDAQ:IRTC) was last updated on 7/3/2024 by MarketBeat.com Staff

From Our Partners